Nufarm Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Nufarm wird ein jährliches Gewinn- und Umsatzwachstum von 66.1% bzw. 7.6% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 39.5% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 6.7% betragen.

Wichtige Informationen

66.1%

Wachstumsrate der Gewinne

39.5%

EPS-Wachstumsrate

Chemicals Gewinnwachstum	34.7%
Wachstumsrate der Einnahmen	7.6%
Zukünftige Eigenkapitalrendite	6.7%
Analystenabdeckung	Good
Zuletzt aktualisiert	18 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

An Intrinsic Calculation For Nufarm Limited (ASX:NUF) Suggests It's 49% Undervalued

May 26

Is There An Opportunity With Nufarm Limited's (ASX:NUF) 30% Undervaluation?

Feb 14

We Think Nufarm (ASX:NUF) Can Stay On Top Of Its Debt

Dec 17

Nufarm Limited (ASX:NUF) On The Verge Of Breaking Even

Mar 01

How Much Of Nufarm Limited (ASX:NUF) Do Insiders Own?

Feb 09

We Think Nufarm (ASX:NUF) Has A Fair Chunk Of Debt

Jan 22

How Much Are Nufarm Limited (ASX:NUF) Insiders Spending On Buying Shares?

Jan 04

Nufarm's (ASX:NUF) Stock Price Has Reduced 50% In The Past Three Years

Dec 14

Does Nufarm's (ASX:NUF) CEO Salary Compare Well With Industry Peers?

Nov 23

Gewinn- und Umsatzwachstumsprognosen

ASX:NUF - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (AUD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
9/30/2027	4,115	165	182	356	11
9/30/2026	3,885	123	67	322	12
9/30/2025	3,584	68	-70	257	12
9/30/2024	3,346	-26	219	472	N/A
6/30/2024	3,315	-16	99	349	N/A
3/31/2024	3,284	-5	-22	226	N/A
12/31/2023	3,382	47	-187	50	N/A
9/30/2023	3,481	100	-352	-126	N/A
6/30/2023	3,521	125	-338	-130	N/A
3/31/2023	3,562	149	-324	-134	N/A
12/31/2022	3,667	125	-63	113	N/A
9/30/2022	3,773	100	199	360	N/A
6/30/2022	3,752	98	178	333	N/A
3/31/2022	3,732	95	157	306	N/A
12/31/2021	3,474	76	219	365	N/A
9/30/2021	3,216	58	282	424	N/A
9/30/2020	1,604	-557	-883	-780	N/A
7/31/2020	2,847	-376	-400	-232	N/A
4/30/2020	2,699	-254	-165	20	N/A
1/31/2020	2,551	-131	71	272	N/A
10/31/2019	2,612	-77	-3	185	N/A
7/31/2019	2,674	-22	-77	98	N/A
4/30/2019	2,772	-57	-267	-92	N/A
1/31/2019	2,871	-91	-458	-281	N/A
10/31/2018	3,090	-59	-370	-185	N/A
7/31/2018	3,308	-26	N/A	-88	N/A
4/30/2018	3,260	35	N/A	-41	N/A
1/31/2018	3,211	96	N/A	5	N/A
10/31/2017	3,161	99	N/A	30	N/A
7/31/2017	3,111	103	N/A	55	N/A
4/30/2017	3,037	115	N/A	146	N/A
1/31/2017	2,964	127	N/A	236	N/A
10/31/2016	2,877	72	N/A	187	N/A
7/31/2016	2,791	16	N/A	137	N/A
4/30/2016	2,766	-33	N/A	166	N/A
1/31/2016	2,741	-83	N/A	194	N/A
10/31/2015	2,739	-26	N/A	211	N/A
7/31/2015	2,737	31	N/A	229	N/A
4/30/2015	2,703	30	N/A	290	N/A
1/31/2015	2,668	30	N/A	351	N/A
10/31/2014	2,645	28	N/A	310	N/A
7/31/2014	2,623	25	N/A	268	N/A
4/30/2014	2,552	52	N/A	92	N/A
1/31/2014	2,481	79	N/A	-85	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: NUF wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als schnelleres Wachstum als die Sparquote angesehen wird (2.6%).

Ertrag vs. Markt: NUF wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als überdurchschnittliches Marktwachstum angesehen wird.

Hohe Wachstumserträge: NUF wird voraussichtlich in den nächsten 3 Jahren rentabel werden.

Einnahmen vs. Markt: NUFDie Einnahmen des Unternehmens (7.6% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Australian (5.7% pro Jahr).

Hohe Wachstumseinnahmen: NUFDie Einnahmen des Unternehmens (7.6% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: NUFDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (6.7%).

Nufarm Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Price target decreased by 12% to AU$5.07

Price target decreased by 7.9% to AU$6.20

Consensus EPS estimates increase by 11%, revenue downgraded

Consensus revenue estimates increase by 13%

Price target increased to AU$6.65

Consensus forecasts updated

Recent updates

Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Here's What's Concerning About Nufarm's (ASX:NUF) Returns On Capital

Independent Non-Executive Chairman recently bought AU$291k worth of stock

Price target decreased by 12% to AU$5.07

Nufarm (ASX:NUF) Is Reducing Its Dividend To A$0.04

First half dividend reduced to AU$0.04

First half 2024 earnings: EPS and revenues miss analyst expectations

Returns On Capital Signal Difficult Times Ahead For Nufarm (ASX:NUF)

Potential Upside For Nufarm Limited (ASX:NUF) Not Without Risk

We Think Nufarm (ASX:NUF) Is Taking Some Risk With Its Debt

Nufarm Limited to Report First Half, 2024 Results on May 16, 2024

Investors Met With Slowing Returns on Capital At Nufarm (ASX:NUF)

MD, CEO & Executive Director exercised options to buy AU$923k worth of stock.

Nufarm Limited, Annual General Meeting, Feb 01, 2024

Nufarm's (ASX:NUF) Dividend Will Be Reduced To A$0.05

Nufarm Limited Announces Final Dividend for the Period of Six Months Ended 30 September 2023, Payable on 15 December 2023

Nufarm Limited Announces Director Resignations

Full year 2023 earnings released

Is Now The Time To Put Nufarm (ASX:NUF) On Your Watchlist?

MD, CEO & Executive Director exercised options to buy AU$692k worth of stock.

Price target decreased by 7.9% to AU$6.20

Are Investors Undervaluing Nufarm Limited (ASX:NUF) By 33%?

Nufarm's (ASX:NUF) Returns On Capital Not Reflecting Well On The Business

If EPS Growth Is Important To You, Nufarm (ASX:NUF) Presents An Opportunity

High number of new directors

Nufarm Limited Announces Board Changes

Is Nufarm (ASX:NUF) A Risky Investment?

Consensus EPS estimates increase by 11%, revenue downgraded

Nufarm (ASX:NUF) Is Paying Out A Larger Dividend Than Last Year

Nufarm Limited Announces Distribution for the Six Months Ended March 31, 2023, Payable on June 9, 2023

Estimating The Fair Value Of Nufarm Limited (ASX:NUF)

First half 2023 earnings released: EPS: AU$0.38 (vs AU$0.25 in 1H 2022)

MD, CEO & Executive Director recently bought AU$80k worth of stock

Here's Why We Think Nufarm (ASX:NUF) Is Well Worth Watching

Independent Non-Executive Director recently bought AU$50k worth of stock

These 4 Measures Indicate That Nufarm (ASX:NUF) Is Using Debt Reasonably Well

Now 21% undervalued

Now 21% undervalued

Nufarm Limited, Annual General Meeting, Feb 02, 2023

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Broker Revenue Forecasts For Nufarm Limited (ASX:NUF) Are Surging Higher

Consensus revenue estimates increase by 13%

Nufarm Limited Declares Final Dividend for the Period Ended September 30, 2022, Payable on December 9, 2022

Nufarm Limited Appoints Alexandra Gartmann as Non-Executive Director with Effect from 23 September 2022

Here's Why Nufarm (ASX:NUF) Can Manage Its Debt Responsibly

Nufarm Limited (ASX:NUF) acquired Energy cane production assets of GranBio group from GranBio Investimentos S.A. for $25 million.

Nufarm Limited Announces the Resignation of Toshikazu Takasaki as A Non-Independent Non-Executive Director

An Intrinsic Calculation For Nufarm Limited (ASX:NUF) Suggests It's 49% Undervalued

Investor sentiment deteriorated over the past week

First half 2022 earnings released

Nufarm Limited Announces Distribution for the Six Months Ended March 31, 2022, Payable on June 17, 2022

Price target increased to AU$6.65

Consensus forecasts updated

Now 20% undervalued

Nufarm Limited Announces Company Secretary Changes

Is There An Opportunity With Nufarm Limited's (ASX:NUF) 30% Undervaluation?

Price target increased to AU$6.02

Nufarm Limited Provides Earnings Guidance for the Year 2022

Nufarm Limited Announces Executive Changes

We Think Nufarm (ASX:NUF) Can Stay On Top Of Its Debt

Full year 2021 earnings released

Forecast breakeven pushed back to 2022

MD, CEO & Executive Director recently bought AU$97k worth of stock

Nufarm Limited (ASX:NUF) On The Verge Of Breaking Even

New 90-day high: AU$5.02

Nufarm Limited, Annual General Meeting, Dec 17, 2021

How Much Of Nufarm Limited (ASX:NUF) Do Insiders Own?

We Think Nufarm (ASX:NUF) Has A Fair Chunk Of Debt

New 90-day high: AU$4.55